This study aims to evaluate the efficacy of rectal ozone therapy as a neuroprotective modality in Pediatric acquired brain injury.
Acquired brain injury (ABI) from primary neurologic diagnoses accounts for 20% of all pediatric critical care admissions and more than 60,000 hospital admissions annually. Ozone (O3) gas was discovered in the 1840s, and soon after that, the scientific community began to expand past the notion that it was just another gas of the Earth's atmosphere.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
120
Patients will receive 40 Rectal ozone sessions or until improvement (maximum 80 sessions), in addition to their conventional rehabilitation program.
Patients will receive their conventional rehabilitation program only (physiotherapy sessions three times per week for the treatment period (six months).
Al-Azhar University
Cairo, Egypt
RECRUITINGAssessment of muscle Tone
Assessment of muscle tone (degree of spasticity) of affected child according to Modified Ashworth's Scale. Ashworth's scale is a 6-point scale, from 0 to 4, with higher scores indicating greater spasticity.
Time frame: 6 months post-sessions
Incidence of reduction in neuroinflammation
Incidence of reduction in neuroinflammation will be recorded.
Time frame: 6 months post-sessions
Assessment of quality of life
Assessment of quality of life including emotional well-being or social interaction will be recorded.
Time frame: 6 months post-sessions
Incidence of adverse effects
Incidence of adverse effects will be recorded.
Time frame: 6 months post-sessions
Measurement of age-related response variability
Age-related response variability by evaluating how different age groups respond to treatment will be recorded.
Time frame: 6 months post-sessions
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.